



































Pluripotent human embryonic stem cells (hESCs) are 
derived from the inner cell mass (ICM) of spare 
blastocysts and are able to differentiate into various cell 
types. Therefore, these cells are often used as an in vitro 
model of the ICM. Recent studies suggest that a 
chromosomally aberrant cell population is present in 
nearly all human spare embryos at the cleavage stage 
[1-3]. However, newborns are characterized by a 
reduced frequency of chromosomal abnormalities when 
compared to preimplantation embryos [4]. In vivo, the 
pluripotent cell state is maintained for a very limited 
time; however, hESCs can be grown indefinitely in 
culture and their capacity to self renew and to 
differentiate into any cell type can be preserved for 
prolonged periods of time. These unique properties 
make hESCs  very  attractive  as  a  potential  source  of  
 
 


































cells for therapeutic usage. Clearly, the genome stability 
of hESCs is an important issue to be considered prior to 
use in clinical applications because even small genomic 
changes can significantly impair cell functionality and 
safety. Several reports have provided evidence of 
remarkable karyotype stability maintained by some 
hESC lines over the course of more than 140 -180 
passages in vitro [5-6]. However, high-resolution 
karyotyping methods have established that hESCs 
acquire chromosomal abnormalities during long-term 
passaging in vitro, namely new sites of heterozygosity 
loss (LOH) and changes in copy-number variations 
(CNVs) [7, 8]. It is possible that the chromosomal 
aberrations observed in hESCs might reflect events 
similar to those that occur in a developing embryo at the 
blastocyst stage. Later in development, cells with 
normal karyotypes are selected by an unknown 



















the  ultimate  cause  of  the  formation  of  chromosomal  aberrations.  Using  G2  radiosensitivity  assay,  we  analyzed
chromosomal aberrations in pluripotent stem cells and somatic cells. The chromatid exchange aberration rates in hESCs
increased  manifold  2  hours  after  irradiation  as  compared  with  their  differentiated  derivatives,  but  the  frequency  of
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double strand breaks (DSBs) by homologous 
recombination (HR) could be the source of the LOH 
arising in hESCs during cultivation while CNVs could 
potentially result from DSB repair by non-allelic 
homologous recombination (NAHR), non-homologous 
end joining (NHEJ) or microhomology-mediated end 
joining [9, 10]. A recent study aimed at characterizing 
DNA repair in hESCs indicates that HR is the major, if 
not the sole, mechanism of DSB repair in pluripotent 
human cells compared to differentiated somatic cells, 
which typically use NHEJ [11]. However, more recently 
Adams et al. [12] provided evidence demonstrating 
NHEJ functionality in hESCs and showed that two 
closely-spaced DSBs induced by I-Sce endonuclease 
can be repaired with high fidelity by NHEJ in hESCs. 
NHEJ activity can result in chromosomal 
rearrangements when multiple DSBs coincide in space 
and time [13]. The aim of this study is to determine the 
repair accuracy of multiple radiation-induced DSBs in 
human pluripotent cells. To investigate the level of DSB 
misrejoining in pluripotent and somatic cells, we used a 
G2-chromosomal radiosensitivity assay [14]. We 
analyzed radiation-induced chromosomal aberrations in 
solid-stained metaphases 2 hours following irradiation, 
i.e., the cytogenetic analysis involved only cells 
irradiated during the late G2 stage of the cell cycle after 
transition through the G2/M checkpoint [15]. The 
design of this G2-assay allowed us to overcome the 
prominent differences in sensitivity to irradiation of 
pluripotent and somatic cells observed by Filion et al. 
[16] and their differences in cell cycle structure and 
regulation demonstrated by Momčilović et al. [17]. In 
addition, cytogenetic analysis provides a unique 
opportunity to estimate the frequency of misrejoining 
during DSB repair. We used the G2-assay to compare 
the accuracy of repair in pluripotent cells, isogenic 
somatic cells and HS27 primary fibroblasts. We show 
that DNA-PK-dependent NHEJ suppresses the 
formation of chromatid breaks after irradiation during 
late G2, and most of the radiation-induced chromatid 
exchanges observed in hESCs result from DNA-PK 
activity. These data elucidate the mechanisms involved 
in the formation of radiation-induced chromatid 
aberrations and propose that these mechanisms 
contribute to chromosome instability in pluripotent cells 
in vivo. 
 
RESULTS AND DISCUSSION 
 
G2-chromosomal radiosensitivity assay 
 
The G2-chromosomal radiosensitivity assay was used to 
assess the chromosomal aberration frequency in cells 
exposed to 1 Gy of γ-irradiation and harvested 2 hours 
later. Two human embryonic stem cell lines (hESM01, 
hESKM05) had its isogenic somatic cell line: hESM01f 
and hESKM05f represented the fibroblast cell lines 
derived from their respective hESCs. Primary human 
foreskin fibroblasts HS27 were included in the study to 
compare with fibroblast cell lines derived from hESCs. 
For enrichment of somatic cell spectrum and additional 
control of possible effects of in vitro differentiation we 
also introduced another pair of isogenic pluripotent and 
somatic cells: induced pluripotent stem cells iPS12 and 












































Figure  1. Chromatid‐type  aberrations  observed  in
metaphases 2 hours after exposure to γ‐irradiation. (A)
Metaphase  chromosome  spread  prepared  from  iPS12  cells
irradiated at dose of 1 Gy during late G2 stage. Gray triangles
indicate chromatid breaks and gray arrow indicates chromatid
exchange.  (B)  Magnified  images  of  chromosomes  with
chromatid  breaks.  (C)  Magnified  images  of  chromatid
exchanges.  1.2  exchange  of  chromatid  segments  between
different chromosomes ; 3 exchange of chromatid segments
between arms within chromosome; 4 exchange resulting from
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of chromatid fragments, with average frequencies 
detected ranging from 0.01-0.08 per cell (Supplemental 
Table S1). After irradiation at the G2 stage, we 
observed a highly significant increase in the frequency 
of chromatid-type aberrations occurring in 88-100% of 
the metaphases examined for each cell line. Observed 
chromosomal aberrations included both chromatid 
exchanges and numerous chromatid breaks (Figure 1). It 
should be noted that chromatid exchanges are the 
products of fusions of broken ends of chromatids (i.e., 
misrepair of DSBs), while chromatid breaks in the G2-
assay result from the conversion of non-repaired DSBs 
to the visible abnormalities of chromosomes [18]. 
Chromatid exchanges were presented mostly by 
aberrations in which chromatid segments were 
exchanged between different chromosomes (aberrations 
also known as tetraradials), or between arms within 
chromosome. Non-terminal deletion and aberrations 
resulted from the fusion of broken ends of chromatids 
from one arm of a chromosome were also considered to 
be exchanges (Figure 1C). Chromatid exchanges 
detected in the G2-assay can theoretically give rise to 
translocations, pericentric inversions, rings, duplications 
or terminal and interstitial deletions after cytokinesis. 
 
The exposure of pluripotent cells to γ -irradiation yields 
a significantly higher rate (2 - 10 fold) of chromatid 


























trols or to primary HS27 fibroblast cultures. The 
frequency of chromatid exchanges in pluripotent cells 
varied from 0.79 ± 0.08 per cell in hESM01 to 1.02 ± 
0.15 per cell in iPS12. The lowest rate of exchange 
frequency among somatic cell lines was observed in 
hESKM05f (0.09 ± 0.03 per cell), while hESM01f 
demonstrated the highest yield of radiation-induced 
chromatid exchanges (0.36 ± 0.07 per cell) (Figure 2, 
Supplemental Table S3). Thus, highly significant 
differences in the frequency of radiation-induced 
chromatid exchanges were detected for all pairs of 
isogenic pluripotent and somatic cells studied (р < 
0.0001). It should be noted, that virtually all chromatid 
exchanges observed in both cell types were readily 
identified as resulting from non-homologous 
chromosomal interaction. This observation indicates that 
NHEJ or non-allelic HR (NAHR) are potential sources of 
chromatid exchange formation. HR occurs much more 
slowly than NHEJ, and DSB repair by HR typically takes 
at least 7 hours in human fibroblasts [19]. Therefore, 
NHEJ appears to be the pathway responsible for the 
formation of chromatid exchanges observed during the 2 
hours post-irradiation in our G2-assay. 
 
The rate of radiation-induced chromatid breaks was 
similar in isogenic pluripotent and somatic cell lines 
(Figure 2B). Hence, pluripotent cells cannot be 
distinguished from somatic cells on the basis of the 




























Figure  2.  Chromatid‐type  aberration  frequency  was  analyzed  in  pairs of  isogenic  pluripotent  and
somatic cells exposed to 1 Gy of γ‐irradiation at late G2 stage. (А) Chromatid exchanges. (В) Chromatid
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in cells irradiated during late G2 after the transition 
through the G2/M checkpoint. A non-functional G2/M 
checkpoint due to ATM deficiency or ATM inhibition 
can significantly increase the yield of chromatid breaks 
in the G2-assay [20]. Consequently, the stringency of 
G2/M arrest in irradiated cells was examined. To 
determine the stringency of G2/M arrest, we counted 
the number of cells entering mitosis under the same 
conditions used for the G2-assay by pH3 
immunostaining and compared mitotic indexes in 
irradiated and non-irradiated cells (Supplemental Figure 
S2). On average, the mitotic index observed in 
irradiated cells corresponded to approximately 20% of 
the mitotic index observed in non-irradiated cells, and 
no significant differences in the G2/M arrest stringency 
were found between any of the cell lines studied. 
Therefore, the differences observed in the G2-assay 
cannot be explained by differential G2/M checkpoint 
characteristics. 
 
Dose-response of chromatid exchanges induced by 
irradiation in the G2 stage 
 
DSB repair at the G2 stage can potentially utilize both 
NHEJ and HR repair pathways. The formation of 
chromatid exchanges between non-homologous 
chromosomes can be due to either from misrejoining of 
two DSBs in two non-homologous chromosomes by 
NHEJ or from processing of one DSB by NAHR. These 

























mal aberration formation are characterized by different 
types of dose-response curves. A linear curve would 
be expected for the one-hit mechanism because DSBs 
are linearly dependent from dose. However, if 
exchanges are formed by interaction of two DSBs, the 
probability of exchanges should be proportional to the 
square of the number of DSBs, and a quadratic curve 
would be expected for such two-hit events [21]. To 
determine the mechanisms of chromatid exchange 
formation in our system, we analyzed the dose-
response relationship of chromatid exchanges induced 
by irradiation at G2 at 0.25, 0.75, and 1 Gy for 
hESM01, hESM01f and HS27 cell lines. The results of 
cytogenetic analysis are presented in Figure 3 and 
Supplemental Table 4. 
 
We used a linear regression analysis to determine the 
type of dose-response model (linear, linear-quadratic, 
or quadratic) that corresponds with our data. Our 
calculations indicated that the rate of chromatid 
exchanges fit well with the quadratic function 
Y=b0+b1*D2, where Y is the yield of radiation-
induced chromatid exchange, and D is the dose. The 
estimates of dose-effect coefficients are summarized in 
Table 1, and the curves are presented in Figure 3. The 
quadratic dose-response model suggests that the 
radiation-induced chromosomal lesions were produced 
by the interaction of two DSBs. Therefore, we propose 
that DSB misrejoining by NHEJ is the main cause of 



























Figure  3.  The  rate  of  chromatid  exchanges  induced  by γ ‐ irradiation  at  G2  fitted  to
quadratic function in pluripotent hESM01 and differentiated hESM01f and HS27 cells. 
   

















The dose response curve for chromosomal exchange 
aberrations (translocations or dicentrics) induced by γ-
radiation exposure of cells at the G0/G1 phase usually 
includes both linear and quadratic terms: 
Y=b0+b1*D+b2*D2. The linear term is thought to 
represent an interaction of two DSBs produced along a 
single track, and the quadratic term represents 
interactions between DSBs produced independently by 
different tracks [21]. In our case, we observed a clear 
quadratic dose response of exchange yield. A similar 
observation of a purely quadratic dose-response 
relationship for chromatid exchanges in human 
fibroblasts has been previously described by Gotoh et 
al. [22]. This quadratic dose response indicates that 
chromatid exchanges were produced by independent 
radiation-induced DSBs resulting from different tracks 
and that no interactions between radiation-induced 
DSBs and endogenous DSBs occurred in pluripotent 
cells. It should be noted that in hESC lines we observed 
a high spontaneous level of γ-H2AX foci, which are 
well-known surrogate markers of DSBs [23]. High 
spontaneous levels of γ-H2AX foci have been 
demonstrated previously in mouse ESCs [24, 25]. 
Double immunofluorescence staining of hESCs with γ-
H2AX and G2-specific cyclin B1 antibodies revealed 
cell cycle phase-related heterogeneity of γ-H2AX foci 
frequency, with the highest numbers of bright and clear 
γ-H2AX foci observed at the G2 phase (Figure 4). More 
specifically, the mean number of γ-H2AX foci was 
approximately 3 per cyclin B1-positive nucleus but less 
than 0.1 per cyclin B1-negative cell. However, as 
mentioned above, our dose-response analysis indicated 
that hESCs did not have endogeneous DSBs capable of 
interacting with radiation-induced DSBs to form 
chromatid exchanges during late G2. This finding 
indicates that there are no endogenous DSBs in hESCs 
during late G2 after the G2/M checkpoint transition and 


















spontaneous γ-H2AX foci in ES cells are not associated 
with DSBs [25]. 
 
In summary, we can conclude that NHEJ is responsible 
for the misrejoining of DSBs in pluripotent stem cells at 
the late G2 after irradiation. Previously, more accurate 
NHEJ was observed in hESCs using an I-Sce model 
with only two DSB per nucleus [12]. The irradiation at 
a dose of 1 Gy induced approximately 40-80 DSBs per 
nucleus simultaneously in G2-cells [26]. This high level 
of DNA damage revealed an inability of hESCs to 
prevent DSB misrejoining by NHEJ. 
 
DNA-PK is important for NHEJ in hESCs during 
late G2 
 
There are two NHEJ pathways characterized by 
different sets of factors contributing to DNA repair. Fast 
D-NHEJ strictly depends on DNA-PK/XRCC4/LIG4. A 
slow and less accurate B-NHEJ backup pathway relies 
on PARP1/XRCC1/LIG3 [27]. Chromosomal aberra-
tions observed in the G2 assay are formed within 2 
hours after irradiation, and thus, fast repair is more 
likely to play a role in chromatid exchange formation. 
Thus, to study the impact of the D-NHEJ pathway on 
radiation-induced chromatid aberrations in pluripotent 
cells, we used a competitive NU7026 inhibitor which 
effectively blocks DNA-PK [28]. The pluripotent cell 
line, hESKM05, its somatic derivative, hESKM05f, and 
the primary fibroblast cell line, HS27, were chosen for 
the experiments with chemical inhibition of NHEJ. 
 
The NU7026 treatment followed by 1 Gy of γ- 
irradiation resulted in a significant increase in radiation-
induced chromatid breaks in all cell lines studied 
(Figure 5B). The level of chromatid breaks was elevated 
approximately fourfold to an average of 15-18 breaks 




Cell line  b0 ± SE
a b 1 ± SE  p-level for b1  Adjusted R
2
hESM01  0.01 ± 0.04  0.86 ± 0.07  0.01  0.98 
hESM01f  0.02 ± 0.03  0.35 ± 0.05  0.02  0.94 
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pluripotent hESKM05 cells (Figure 5A). The exchange 
rate in hESKM05 cells decreased by 80% (from 1.45 ± 
0.10 per cell to 0.27 ± 0.09 per cell, p < 0.0001) upon 
DNA-PK inhibition. It should be noted that NU7026 
did not cause chromosomal aberrations or additional γ-
H2AX foci without irradiation (Supplemental Table 
S5). Immunostaining with a phospho-H3 antibody 
demonstrated that NU7026 treatment did not alter the 
number of cells that reached metaphase after 
irradiation, i.e. NU7026 didn’t influence G2/M 
checkpoint (data not shown). Thus, our data indicate 
that DNA-PK suppresses the formation of chromatid 










































DNA-PK activity was also associated with a high level 
of misrejoining in hESCs but not in differentiated 
cells. Two recent reports show that DNA-PK does not 
significantly contribute to DSB repair in hESCs [11, 
12]. However, our data indicate that DNA-PK does 
contribute to DSB repair immediately after DNA 
damage in hESCs, at least in G2 cells after passing 
through the G2/M checkpoint. Future studies will be 
required to determine the functionality of DNA-PK 
dependent NHEJ during other phases of cell cycle. The 
genetically modified ES cells or iPS cells derived from 
patients with DNA repair-deficiency disorders will be 
especially useful in studies of DNA repair in 












































Figure 4.  Double  immunofluorescence
staining  of  hESCs  with γ ‐ H2AX  (red)  and




Figure  5.  The  influence  of  NU7026  (50 μ M)  on  the  frequency  of  radiation‐induced  chromatid‐type
aberrations (D = 1 Gy) in hESKM05, hESKM05f and HS27. (A) NU7026 decreased radiation‐induced chromatid
exchanges to no‐zero level in hESCs and had no effect on the level of exchanges in somatic cells. (B) NU7026 treatment
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CNVs in human pluripotent stem cells compared to 
somatic cells [33]. Narva et al. also found that hESC 
cultivation led to changes in CNVs [8]. One can 
speculate that error-prone DNA-PK-dependent NHEJ 
might contribute to these genomic alterations in human 
pluripotent stem cells. 
 
A high mitotic index is typical for cells of the ICM and 
for ES cells. The G2-assay performed in pluripotent 
cells revealed that exposure to radiation induces 
“sticky” ends of broken chromosomes at the premitotic 
stage in these cells. The DSBs misrejoined during G2 
can give rise to a bridge-fusion-bridge cycle and to 
deletions and duplications of chromosome segments 
[34]. Complex chromosome aberrations derived from 
bridge-fusion-bridge cycles have been observed 
previously in blastomeres of cleavage embryos [3]. 
However, hESCs do not demonstrate any prominent 
genome instability, which is common for cleavage 
embryos. Therefore, hESCs can effectively suppress 
endogenous DSBs at the G2 stage, thereby decreasing 
the possibility of aberrant chromatid exchange or can 
block bridge-fusion-bridge cycles via the rapid 
elimination of damaged cells. 
 
Previous work from several groups has shown that the 
error-free HR mechanism predominates in DSB repair 
in mouse and human ES cells [11, 35-36]. Recently, 
Adams et al. [12] provided evidence demonstrating 
NHEJ functionality in hESCs and showed that DSBs 
induced by I-Sce endonuclease can be repaired with 
high fidelity by NHEJ in hESCs through a DNA-PK-
independent mechanism. Our data on G2-chromosomal 
radiosensitivity of human pluripotent stem cells also 
indicates on NHEJ functionality in these cells. 
However, we demonstrate that human pluripotent stem 
cells can effectively utilize a DNA-PK-dependent NHEJ 
mechanism for repair of radiation-induced DSBs during 
the late G2 stage of the cell cycle, prior to entering 
mitosis. Furthermore, we demonstrate that DNA-PK is 
responsible for the excessive misrepair of DSBs 
observed in hESCs compared to somatic cells. 
 
MATERIALS AND METHODS 
 
Cell cultivation. The hESC lines, hESM01 and 
hESKM05, were previously described by Lagarkova et 
al. [37]. Human umbilical vein endothelial cells 
(HUVECs) were derived as described in Baudin et al. 
[38]. The induced pluripotent stem (iPS) cell line, 
iPS12, was derived from HUVECs by lentiviral 
transfection with four transcription factors, KLF4, 
OCT4, SOX2 and C-MYC [39]. Fibroblast-like cells 
hESM01f and hESKM05f were previously established 
from hESM01 and hESKM05, respectively [40]. The 
primary foreskin fibroblast cell line, HS27, was 
obtained from ATCC (ATCC#CRL-1634). A summary 
of the immunocytochemical features of cell lines used 
and representative images of each are presented in 
Supplementary Materials (Supplemental Table S1, 
Supplemental FigureS1). 
 
The pluripotent cell lines were maintained in defined 
medium mTeSR1 (StemCells Technologies) on Petri 
dishes coated with matrix Matrigel (BD). Somatic cell 
lines HS27, hESM01f, and hESKM05f were grown in 
DMEM medium supplemented with 10% fetal bovine 
serum (FBS, Hyclone) and 5 ng/ml hrbFGF 
(Peprotech), 2 mM L-glutamine, 50 units/ml penicillin 
and 50 μg/ml streptomycin (all from Hyclone). HUVEC 
were cultivated in DMEM/F12 with 15% FBS, 5 ng/ml 
hrbFGF (Peprotech), 20 ng/ml hrVEGF (Peprotech), 1% 
nonessential amino acids, 2 mM L-glutamine, 50 
units/ml penicillin and 50 μg/ml streptomycin (all from 




Immunocytochemistry, γH2AX foci and mitotic index 
counting. Cells on Petri dishes were fixed for 10 min 
with 4%PFA/PBS, permeabilized for 20 min with 0.1% 
TritonX100/PBS at room temperature and incubated for 
30 min with blocking solution 2.5%BSA/PBS/0.1% 
Tween20. For γH2AX and cyclin B1 double staining, 
the cells were incubated overnight with monoclonal 
mouse anti-γH2AX (Upstate, 1:1000) and polyclonal 
rabbit anti-cyclin B1 antibodies (Santa-Cruz, 1:100) at 
4oC. For mitotic index counting, the cells were 
incubated overnight with a polyclonal rabbit 
phosphorylated-Histone H3-antibody (pH3, Santa Cruz, 
1:100) at 4oC. After three washing steps in PBS-0.1% 
Tween20, the cells were stained with Alexa Fluor 546 
goat anti-rabbit IgG (Invitrogen, 1:1000) and Alexa 
Fluor 488 goat anti-mouse IgG (Invitrogen, 1:1000) for 
1 hour at room temperature. Cell nuclei were 
counterstained with DAPI. 
 
To estimate the numbers of γH2AX foci in cells at G2, 
the nuclei of cells with bright cyclin B1 staining were 
chosen. To score γH2AX foci in cyclin B1-negative 
cells, the nuclei of cells with cyclin B1-negative 
cytoplasm were selected. To estimate the frequency of 
γH2AX foci, 100 – 200 nuclei were scored. For mitotic 
index counting, the number of pH3-positive nuclei was 
divided by the total number of nuclei. To assess the 
efficiency of the G2/M checkpoint, the mitotic index 
was determined by scoring 3000 -5000 cells. 
 
Irradiation, inhibitor treatment and metaphase 
chromosome preparations. Cells of 70-80% confluency 
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rate 0.1 Gy/min) in Petri dishes at room temperature. 
An inhibitor of DNA-PK, NU7026 (Sigma-Aldrich), 
was diluted in DMSO and added to cultivating media 4 
hours before irradiation at a final concentration of 50 
µM. Thirty minutes after irradiation, colcemid 
(Invitrogene) was added at a final concentration 0.1 
µg/ml. For metaphase chromosome preparations, cells 
were collected 120 min after irradiation. Hypotonic 
treatment (0.075 M KCl) was performed for 18 min at 
42 oC. Cells were fixed with 2 changes of an ice-cold 
methanol: glacial acetic acid mix. The first fixative 
consisted of a mixture of methanol and glacial acetic 
acid at ratio 6:1, and the second fixative consisted of a 
methanol: glacial acetic acid mixture at a 3:1 ratio. 
Fixed cells were stored in fixative (3:1) at 4oC. 
Metaphase slides were made according to standard 
procedures and stained with Giemsa. 
 
Cytogenetic analysis. Euploid metaphases with 46 
chromosomes were analyzed for the presence of 
chromosomal aberrations, including chromatid breaks, 
isochromatid breaks and chromatid exchanges. 
Chromatid discontinuances of lengths greater than the 
width of the chromatid were considered to be chromatid 
breaks. Chromatid discontinuances with lengths less than 
the chromatid width were considered to be chromatid 
gaps and were not counted as aberrations in the present 
analysis. Exchanges included chromatid interchanges 
between two and more chromosomes, chromatid 
intrachanges between arms of a chromosome, non-
terminal deletion and aberrations resulted from the fusion 
of broken ends of chromatids from one arm of a 
chromosome. Examples of chromatid breaks and 
exchanges are presented in Figure 1. 
 
Statistical methods. The distribution of chromatid 
breaks and exchanges in each cell type was in general 
agreement with Poisson distribution (p>0.05, Χ2-test). 
The Poisson standard error of mean (SEM) was used as 
an indicator of dispersion SEM=√n/N, where “n” is the 
number of chromosomal abnormalities observed, and 
“N” is the number of metaphases scored. Statistically 
significant differences in the spontaneous level of 
chromosomal aberrations were estimated using Fisher’s 
exact test. The significance of differences in the 
frequency of radiation-induced chromosomal 
abnormalities was estimated using Pearson’s Χ2-test. 
Differences were considered statistically significant at a 
significance level of p <0.01. Linear regression analysis 
was applied to estimate the dose-response relationships 
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Supplementary  Table  S1.  Immunohistochemical  features  of  pluripotent  stem  cells 
hESM01,  hESKM05, iPS12,  isogeneic fibroblast‐like  derivatives of hESCs,  and HUVEC 
cells parental for iPS12. Markers of pluripotency are shown in bold, fibroblast markers – 
in italic. 
Marker hESM01  hESKM05  iPS12  hESM01f  hESKM05f  HUVEC 
prolyl-4-
hydroxylase 
- -  -  + + + 
CD90  + +  +  + +   
CD105  - -  -  + + + 
vWF -  -  -  -  -  + 
CD31 -  -  -  -  -  + 
CD30 +  +  +  -  -  - 
CD44 -  -  -  +  +  + 
Vimentin +/-  +/-  +/-  +  +  + 
Pan-
cytokeratin 
+ +  +  -  -  - 
GFAP -  -  -  -  -  - 
OCT4  + +  +  -  -  - 
NANOG  + +  +  -  -  - 
SSEA-4  + +  +  -  -  - 
SSEA-3  + +  +  -  -  - 
Tra-1-60  + +  +  -  -   
 
   







































































































and  somatic  cells.  Immunofluorescence  staining  with  pH3‐
antibody (red) and DAPI (blue) counterstaining was performed. 
Supplementary Figure S1. The representative images of cells
used  in  the  study.  (A)  Images  of  pluripotent  cells  hESM01,
hESKM05 and iPS12 cells. Upper row: Phase contrast images of cells.
Bottom row: Immunofluorescence staining with antibodies to OCT4






Cell line  Cells scored 
The frequency of chromatid-type aberrations per 1 cell, ± SEM
a 
Exchanges Breaks 
hESM01  350  0  0.01 ± 0.005 
hESM01f  250  0  0.08 ± 0.02
 
hESKM05 60  0  0.05  ± 0.03 
hESKM05f  100  0  0.04 ± 0.02 
iPS12 155  0  0.01 
HUVEC 100  0  0.01 
HS27 50  0  0.02 
a ‐ SEM – Poisson’s standard error of mean. 
   






































































































Cell line  Cells 
scored 
The frequency of chromatid-type aberrations per 1 cell, ± SEM
b 
Exchanges Breaks 
hESM01  117  0.79 ± 0.08  2.14 ± 0.143 
hESM01f  76  0.36 ± 0.07*  2.91 ± 0.20
 
hESKM05  37  0.97 ± 0.16  5.22 ± 0.38 
hESKM05f  78  0.09 ± 0.03*  5.65 ± 0.27 
iPS12  46  1.02 ± 0.15  4.33 ± 0.31 
HUVEC  106  0.28 ± 0.05*  3.96 ± 0.19 















0  350  0  0.01 ± 0.005 
0.25  47  0.02  0.47 ± 0.10 
0.5  109  0.29 ± 0.05  0.94 ± 0.09 
1  87  0.86 ± 0.10  1.53 ± 0.13 
hESM01f 
0  251  0  0.08 ± 0.02
 
0.25  96  0.02 ± 0.01  0.66 ± 0.08 
0.5  84  0.15 ± 0.04  1.90 ± 0.15 
1  76  0.36 ± 0.07  2.91 ± 0.20 
HS27 
0 50  0  0.02 
0.25  50  0  0.74 ± 0.12 
0.5  50  0.04 ± 0.03  1.48 ± 0.17 
1  103  0.22 ± 0.12  2.62 ± 0.32 
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Supplementary Table S5. The effect of NU7026 treatment on non‐irradiated cells 
 
Cells Inhibitor  Cells 
scored 





no inhibitor  60  0  0.05 ± 0.03 
NU7026 50  0  0.02 
hESKM05f 
no inhibitor  100  0  0.04 ± 0.02 
NU7026 50  0  0.02 
HS27 
no inhibitor  50  0  0.02 




Cells Inhibitor  Cells 
scored 





no inhibitor  76  1.45 ± 0.14  4.00 ± 0.23 
NU7026  37  0.27 ± 0.09*  14.81 ± 0.63* 
hESKM05f 
no inhibitor  40  0.13 ± 0.06  4.75 ± 0.34 
NU7026  25  0.28 ± 0.11  17.48 ± 0.84* 
HS27 
no inhibitor  78  0.18 ± 0.05  2.63 ± 0.18 
NU7026  50  0.22 ± 0.07  17.12 ± 0.59* 
* ‐ yield of aberrations significantly differs from values observed in cells non‐treated with inhibitors, Χ
2‐ test,  
p < 0.0001 